Food and Drug Administration approved leucovorin for cerebral folate transport deficiency, an ultra-rare genetic neurological disease associated with specific genetic changes, but the drug was not approved for autism spectrum disorder
The preclinical findings are promising enough to generate interest in the longevity and athletic performance communities, but they do not constitute proof of specific outcomes in any individual human user
Genes-basel 7 , 58 (2016)
The L-carnitine-supplemented group showed a dose-dependent reduction in the levels of ACE2, TMPRSS2 and furin with the maximum effect observed at 200 mg/kg/day, which translates to 2,000 mg HED
Adeva-Andany MM, Calvo-Castro I, Fernndez-Fernndez C, Donapetry-Garca C, Pedre-Pieiro AM
B12 shots vs